Zhejiang Hisun Pharmaceutical's low P/E ratio may be due to ...
Zhejiang Hisun Pharmaceutical's low P/E ratio may be due to market expectations of declining earnings. The weak earnings outlook could be causing the low share price, making it hard for the price to rise significantly soon.
Benign Growth For Zhejiang Hisun Pharmaceutical Co., Ltd. (SHSE:600267) Underpins Stock's 27% Plummet
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment